Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42


Vimentin expression is retained in erythroid cells differentiated from human iPSC and ESC and indicates dysregulation in these cells early in differentiation.

Trakarnsanga K, Ferguson D, Daniels DE, Griffiths RE, Wilson MC, Mordue KE, Gartner A, Andrienko TN, Calvert A, Condie A, McCahill A, Mountford JC, Toye AM, Anstee DJ, Frayne J.

Stem Cell Res Ther. 2019 Apr 29;10(1):130. doi: 10.1186/s13287-019-1231-z.


Gold Nanoparticle-Based Fluorescent Theranostics for Real-Time Image-Guided Assessment of DNA Damage and Repair.

Srinivasan SS, Seenivasan R, Condie A, Gerson SL, Wang Y, Burda C.

Int J Mol Sci. 2019 Jan 22;20(3). pii: E471. doi: 10.3390/ijms20030471.


Robust Revascularization in Models of Limb Ischemia Using a Clinically Translatable Human Stem Cell-Derived Endothelial Cell Product.

MacAskill MG, Saif J, Condie A, Jansen MA, MacGillivray TJ, Tavares AAS, Fleisinger L, Spencer HL, Besnier M, Martin E, Biglino G, Newby DE, Hadoke PWF, Mountford JC, Emanueli C, Baker AH.

Mol Ther. 2018 Jul 5;26(7):1669-1684. doi: 10.1016/j.ymthe.2018.03.017. Epub 2018 Mar 28.


Inhibition of uracil DNA glycosylase sensitizes cancer cells to 5-fluorodeoxyuridine through replication fork collapse-induced DNA damage.

Yan Y, Han X, Qing Y, Condie AG, Gorityala S, Yang S, Xu Y, Zhang Y, Gerson SL.

Oncotarget. 2016 Sep 13;7(37):59299-59313. doi: 10.18632/oncotarget.11151.


High-Efficiency Serum-Free Feeder-Free Erythroid Differentiation of Human Pluripotent Stem Cells Using Small Molecules.

Olivier EN, Marenah L, McCahill A, Condie A, Cowan S, Mountford JC.

Stem Cells Transl Med. 2016 Oct;5(10):1394-1405. Epub 2016 Jul 8.


A Fluorescent Probe to Measure DNA Damage and Repair.

Condie AG, Yan Y, Gerson SL, Wang Y.

PLoS One. 2015 Aug 26;10(8):e0131330. doi: 10.1371/journal.pone.0131330. eCollection 2015.


Two-photon fluorescent imaging of myelination in the spinal cord.

Condie AG, Gerson SL, Miller RH, Wang Y.

ChemMedChem. 2012 Dec;7(12):2194-203. doi: 10.1002/cmdc.201200343. Epub 2012 Nov 7.


Functionally diverse nucleophilic trapping of iminium intermediates generated utilizing visible light.

Freeman DB, Furst L, Condie AG, Stephenson CR.

Org Lett. 2012 Jan 6;14(1):94-7. doi: 10.1021/ol202883v. Epub 2011 Dec 8.


Intercepting Wacker intermediates with arenes: C-H functionalization and dearomatization.

Matsuura BS, Condie AG, McBee IA, Buff RC, Karahalis GJ, Stephenson CR.

Org Lett. 2011 Dec 2;13(23):6320-3. doi: 10.1021/ol202881q. Epub 2011 Nov 9. Erratum in: Org Lett. 2012 Feb 17;14(4):1184. McBee, Ian A [added].


A novel PET marker for in vivo quantification of myelination.

Wu C, Wang C, Popescu DC, Zhu W, Somoza EA, Zhu J, Condie AG, Flask CA, Miller RH, Macklin W, Wang Y.

Bioorg Med Chem. 2010 Dec 15;18(24):8592-9. doi: 10.1016/j.bmc.2010.10.018. Epub 2010 Nov 9.


Visible-light photoredox catalysis: aza-Henry reactions via C-H functionalization.

Condie AG, González-Gómez JC, Stephenson CR.

J Am Chem Soc. 2010 Feb 10;132(5):1464-5. doi: 10.1021/ja909145y.


A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression.

Knight HM, Pickard BS, Maclean A, Malloy MP, Soares DC, McRae AF, Condie A, White A, Hawkins W, McGhee K, van Beck M, MacIntyre DJ, Starr JM, Deary IJ, Visscher PM, Porteous DJ, Cannon RE, St Clair D, Muir WJ, Blackwood DH.

Am J Hum Genet. 2009 Dec;85(6):833-46. doi: 10.1016/j.ajhg.2009.11.003.


Synthesis of calixarene-capped carbosilane dendrimers.

Lambert JB, Kang SH, Ma K, Liu C, Condie AG.

J Org Chem. 2009 Mar 20;74(6):2527-32. doi: 10.1021/jo802714q.


A common variant in the 3'UTR of the GRIK4 glutamate receptor gene affects transcript abundance and protects against bipolar disorder.

Pickard BS, Knight HM, Hamilton RS, Soares DC, Walker R, Boyd JK, Machell J, Maclean A, McGhee KA, Condie A, Porteous DJ, St Clair D, Davis I, Blackwood DH, Muir WJ.

Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14940-5. doi: 10.1073/pnas.0800643105. Epub 2008 Sep 29.


An animal model to evaluate the function and regulation of the adaptively evolving stress protein SEP53 in oesophageal bile damage responses.

Nelson L, Anderson S, Archibald AL, Rhind S, Lu ZH, Condie A, McIntyre N, Thompson J, Nenutil R, Vojtesek B, Whitelaw CB, Little TJ, Hupp T.

Cell Stress Chaperones. 2008 Sep;13(3):375-85. doi: 10.1007/s12192-008-0037-1. Epub 2008 May 9.


Making "sense" of DNA.

Stokes GY, Gibbs-Davis JM, Boman FC, Stepp BR, Condie AG, Nguyen ST, Geiger FM.

J Am Chem Soc. 2007 Jun 20;129(24):7492-3. Epub 2007 May 24. No abstract available.


Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population.

Thomson PA, Wray NR, Millar JK, Evans KL, Hellard SL, Condie A, Muir WJ, Blackwood DH, Porteous DJ.

Mol Psychiatry. 2005 Jul;10(7):657-68, 616.


Epistatic interactions between modifier genes confer strain-specific redundancy for Tgfb1 in developmental angiogenesis.

Tang Y, Lee KS, Yang H, Logan DW, Wang S, McKinnon ML, Holt LJ, Condie A, Luu MT, Akhurst RJ.

Genomics. 2005 Jan;85(1):60-70.


Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor.

Thomson PA, Wray NR, Thomson AM, Dunbar DR, Grassie MA, Condie A, Walker MT, Smith DJ, Pulford DJ, Muir W, Blackwood DH, Porteous DJ.

Mol Psychiatry. 2005 May;10(5):470-8.


Analysis of the Fanconi anaemia complementation group A gene in acute myeloid leukaemia.

Condie A, Powles RL, Hudson CD, Shepherd V, Bevan S, Yuille MR, Houlston RS.

Leuk Lymphoma. 2002 Sep;43(9):1849-53.


Instability of CAG-trinucleotide repeats in chronic lymphocytic leukemia.

Benzow KA, Koob MD, Condie A, Catovsky D, Matutes E, Yuille MR, Houlston RS.

Leuk Lymphoma. 2002 Oct;43(10):1987-90.


ATM mutations are rare in familial chronic lymphocytic leukemia.

Yuille MR, Condie A, Hudson CD, Bradshaw PS, Stone EM, Matutes E, Catovsky D, Houlston RS.

Blood. 2002 Jul 15;100(2):603-9.


Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia.

Yuille M, Condie A, Hudson C, Kote-Jarai Z, Stone E, Eeles R, Matutes E, Catovsky D, Houlston R.

Blood. 2002 Jun 1;99(11):4216-8.


Breakpoints in the ataxia telangiectasia gene arise at the RGYW somatic hypermutation motif.

Bradshaw PS, Condie A, Matutes E, Catovsky D, Yuille MR.

Oncogene. 2002 Jan 17;21(3):483-7.


Disruption of the ATM gene in breast cancer.

Lu Y, Condie A, Bennett JD, Fry MJ, Yuille MR, Shipley J.

Cancer Genet Cytogenet. 2001 Apr 15;126(2):97-101.


TCL1 is activated by chromosomal rearrangement or by hypomethylation.

Yuille MR, Condie A, Stone EM, Wilsher J, Bradshaw PS, Brooks L, Catovsky D.

Genes Chromosomes Cancer. 2001 Apr;30(4):336-41.


Vaccinia virus replication is independent of cellular HSP72 expression which is induced during virus infection.

Sedger L, Ramshaw I, Condie A, Medveczky J, Braithwaite A, Ruby J.

Virology. 1996 Nov 15;225(2):423-7.


Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene.

Prosser J, Inglis JD, Condie A, Ma K, Kerr S, Thakrar R, Taylor K, Cameron JM, Cooke HJ.

Mamm Genome. 1996 Nov;7(11):835-42.


APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis.

Prosser J, Condie A, Wright M, Horn JM, Fantes JA, Wyllie AH, Dunlop MG.

Br J Cancer. 1994 Nov;70(5):841-6.


Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D, et al.

Cancer Res. 1994 Mar 1;54(5):1298-304.


Nonsense and missense mutations in the muscular chloride channel gene Clc-1 of myotonic mice.

Gronemeier M, Condie A, Prosser J, Steinmeyer K, Jentsch TJ, Jockusch H.

J Biol Chem. 1994 Feb 25;269(8):5963-7.


Exclusion of constitutional p53 mutations as a cause of genetic susceptibility to colorectal cancer.

Bhagirath T, Condie A, Dunlop MG, Wyllie AH, Prosser J.

Br J Cancer. 1993 Oct;68(4):712-4. No abstract available.


p53 mutations in breast cancer.

Coles C, Condie A, Chetty U, Steel CM, Evans HJ, Prosser J.

Cancer Res. 1992 Oct 1;52(19):5291-8.


Zinc finger point mutations within the WT1 gene in Wilms tumor patients.

Little MH, Prosser J, Condie A, Smith PJ, Van Heyningen V, Hastie ND.

Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4791-5.


Constitutional p53 mutation in a non-Li-Fraumeni cancer family.

Prosser J, Porter D, Coles C, Condie A, Thompson AM, Chetty U, Steel CM, Evans HJ.

Br J Cancer. 1992 Apr;65(4):527-8. No abstract available.


p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters.

Thompson AM, Anderson TJ, Condie A, Prosser J, Chetty U, Carter DC, Evans HJ, Steel CM.

Int J Cancer. 1992 Feb 20;50(4):528-32.


A familial RB1 mutation detected by the HOT technique is homozygous in a second primary neoplasm.

Weir-Thompson E, Condie A, Leonard RC, Prosser J.

Oncogene. 1991 Dec;6(12):2353-6.


Biallelic ApaI polymorphism of the human p53 gene (TP53).

Prosser J, Condie A.

Nucleic Acids Res. 1991 Sep 11;19(17):4799. No abstract available.


Mutations in p53 do not account for heritable breast cancer: a study in five affected families.

Prosser J, Elder PA, Condie A, MacFadyen I, Steel CM, Evans HJ.

Br J Cancer. 1991 Feb;63(2):181-4. No abstract available.


Mapping and characterization of mutants of the Escherichia coli cell division gene, ftsA.

Robinson AC, Begg KJ, Sweeney J, Condie A, Donachie WD.

Mol Microbiol. 1988 Sep;2(5):581-8. Erratum in: Mol Microbiol 1989 Feb;3(2):267.


The treatment of bacteriuria in pregnant women with sulphamethoxazole and thrimethoprim. A microbiological, clinical and toxicological study.

Williams JD, Brumfitt W, Condie AP, Reeves DS.

Postgrad Med J. 1969 Nov;45:Suppl:71-6. No abstract available.


Supplemental Content

Loading ...
Support Center